Skip to main content
SpringerLink
Log in

Less toxicity with targeted therapies spells lower costs

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Niraula S, et al. Risk of Incremental Toxicities and Associated Costs of New Anticancer Drugs: A Meta-Analysis. Journal of Clinical Oncology : 29 Sep 2014. Available from: URL: http://doi.org/10.1200/JCO.2014.55.8437.

    PubMed  Google Scholar 

  2. Hermanson T, et al. Toxicity and Costs of Toxicity Associated With New Cancer Drugs: International Implications. Journal of Clinical Oncology : 29 Sep 2014.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Less toxicity with targeted therapies spells lower costs. PharmacoEcon Outcomes News 713, 20 (2014). https://doi.org/10.1007/s40274-014-1605-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1605-5

Search

Navigation